QUANTUM X LABS INC.
For the period ended Dec 31, 2024. Filed Mar 21, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 21, 2025
QXL$3.38-8.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Shareholders’ Equity
| Common stock (*) · Additional paid-in · Accumulated · Total Attributed to the company’s · Non- Controlling · Total | ||||||||
|---|---|---|---|---|---|---|---|---|
| Number · Amount · capital · Deficit · Shareholders · Interests · Equity | ||||||||
| Balance as of January 1, 2024 | 3,732,169 | 3 | 25,476 | (10,661) | 14,818 | 3,806 | 18,624 | |
| Net loss | - | - | - | (12,053) | (12,053) | (2,053) | (14,106) | |
| Share-based compensation (see notes 14.A, 14.F) | - | - | 12 | - | 12 | (1) | 11 | |
| Expiration of options granted to subsidiaries’ employees | - | - | 16 | - | 16 | (16) | - | |
| Issuance of shares upon RSUs vesting (see note 14.F) | 6,378 | -(** | ) | - | - | - | - | - |
| Issuance of shares to consultants (see note 14.A) | 120,000 | -(** | ) | 57 | - | 57 | - | 57 |
| Issuance of shares and warrants in connection with short-term loan and convertible loans (see notes 10, 14.A) | 1,168,679 | -(** | ) | 890 | - | 890 | - | 890 |
| Issuance of shares and warrants in connection with private placement (see note 14.B) | 269,719 | -(** | ) | 198 | - | 198 | - | 198 |
| Reclassification of derivative warrant liability to equity (see note 10.E) | - | - | 1,833 | - | 1,833 | - | 1,833 | |
| Balance as of December 31, 2024 | 5,296,945 | 3 | 28,482 | (22,714) | 5,771 | 1,736 | 7,507 | |
| (*) | Share and per share data in these financial statements have been retrospectively adjusted, for all periods presented, to reflect a number of shares that is equivalent to the number of shares of the Company post the Reverse Stock Split (see note 14.D). |
| (**) | Represents an amount less than $1. |
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
| Common stock (*) · Additional paid-in · Accumulated · Total Attributed to the company’s · Non- Controlling · Total | ||||||||
|---|---|---|---|---|---|---|---|---|
| Number · Amount · capital · Deficit · Shareholders · Interests · Equity | ||||||||
| Balance as of January 1, 2023 | 3,698,013 | 3 | 25,350 | (3,338) | 22,015 | 7,884 | 29,899 | |
| Net loss | - | - | - | (7,323) | (7,323) | (1,364) | (8,687) | |
| Share-based compensation (see notes 14.A, 14.F) | 34,156 | -(** | ) | 71 | - | 71 | 64 | 135 |
| Transaction with non-controlling interests (see note 7.A) | - | - | - | - | - | (2,625) | (2,625) | |
| Dividend declared to non-controlling interests (see note 14.G) | (153) | (153) | ||||||
| Issuance of warrants in connection with loan agreement (see note 10.D) | - | - | 55 | - | 55 | - | 55 | |
| Balance as of December 31, 2023 | 3,732,169 | 3 | 25,476 | (10,661) | 14,818 | 3,806 | 18,624 | |
| (*) | Share and per share data in these financial statements have been retrospectively adjusted, for all periods presented, to reflect a number of shares that is equivalent to the number of shares of the Company post the Reverse Stock Split (see note 14.D). |
| (**) | Represents an amount less than $1. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.